Gotenba, Japan

Shinya Fujiwara

This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinya Fujiwara. Retrieved from https://idiyas.com/inventor/shinya-fujiwara-0e0krmcn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shinya Fujiwara: Innovator in Thrombopoietin-Like Compounds

Introduction

Shinya Fujiwara is a notable inventor based in Gotenba, Japan. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that exhibit thrombopoietin-like activities. His work has the potential to impact medical treatments related to blood disorders.

Latest Patents

Fujiwara holds a patent for "Compounds exhibiting thrombopoietin-like activities." The compounds of this invention are represented by a specific general formula, where various groups and residues are defined to exhibit thrombopoietin-like activity. This innovation is crucial for advancing therapeutic options in hematology.

Career Highlights

Fujiwara is associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His role in the company has allowed him to focus on innovative research and development in the field of medicinal chemistry. His expertise has led to the successful patenting of his work.

Collaborations

Fujiwara has collaborated with notable colleagues, including Kunihiro Hattori and Toshiro Kozono. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Shinya Fujiwara's contributions to the field of thrombopoietin-like compounds highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new therapeutic possibilities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…